Infectious Diseases (except HIV/AIDS)

  1. Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine

    1. Karen J. Hager
    2. Gonzalo Pérez Marc
    3. Philipe Gobeil
    4. Ricardo S. Diaz
    5. Gretchen Heizer
    6. Conrado Llapur
    7. Alexander I. Makarkov
    8. Eduardo Vasconcellos
    9. Stéphane Pillet
    10. Fernando Riera
    11. Pooja Saxena
    12. Priscila Geller Wolff
    13. Kapil Bhutada
    14. Garry Wallace
    15. Hessam Aazami
    16. Christine E. Jones
    17. Fernando P. Polack
    18. Luciana Ferrara
    19. Judith Atkins
    20. Iohann Boulay
    21. Jiwanjeet Dhaliwall
    22. Nathalie Charland
    23. Manon M.J. Couture
    24. Julia Jiang-Wright
    25. Nathalie Landry
    26. Sophie Lapointe
    27. Aurélien Lorin
    28. Asif Mahmood
    29. Lawrence H. Moulton
    30. Emmy Pahmer
    31. Julie Parent
    32. Annie Séguin
    33. Luan Tran
    34. Thomas Breuer
    35. Maria-Angeles Ceregido
    36. Marguerite Koutsoukos
    37. François Roman
    38. Junya Namba
    39. Marc-André D’Aoust
    40. Sonia Trepanier
    41. Yosuke Kimura
    42. Brian J. Ward

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. N Gene Target Failure (NGTF) for detection of Omicron: a way out for the ‘stealth’ too?

    1. Shivangi Harankhedkar
    2. Gaurav Chatterjee
    3. Sweta Rajpal
    4. Afreen Khan
    5. Tuhina Srivastava
    6. Sumeet Mirgh
    7. Anant Gokarn
    8. Sachin Punatar
    9. Nitin Shetty
    10. Amit Joshi
    11. Sudhir Nair
    12. Vedang Murthy
    13. Prashant Tembhare
    14. Ashwini More
    15. Sujeet Kamtalwar
    16. Preeti Chavan
    17. Vivek Bhat
    18. Amar Patil
    19. Sachin Dhumal
    20. Prashant Bhat
    21. Papagudi Subramanian
    22. Rachana Tripathi
    23. Shesheer Munipally
    24. Sumeet Gujral
    25. Navin Khattry
    26. Sudeep Gupta
    27. Nikhil Patkar

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Quantitative risk assessment of COVID-19 and serious illness among spectators at mass gathering events with vaccine-testing package implementation

    1. Michio Murakami
    2. Tsukasa Fujita
    3. Yuichi Iwasaki
    4. Masaki Onishi
    5. Wataru Naito
    6. Seiya Imoto
    7. Tetsuo Yasutaka

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste

    1. Geoffrey Chupp
    2. Anne Spichler-Moffarah
    3. Ole S. Søgaard
    4. Denise Esserman
    5. James Dziura
    6. Lisa Danzig
    7. Reetika Chaurasia
    8. Kailash P. Patra
    9. Aryeh Salovey
    10. Angela Nunez
    11. Jeanine May
    12. Lauren Astorino
    13. Amisha Patel
    14. Stephanie Halene
    15. Jianhui Wang
    16. Pei Hui
    17. Prashant Patel.
    18. Jing Lu
    19. Fangyong Li
    20. Geliang Gan
    21. Stephen Parziale
    22. Lily Katsovich
    23. Gary V. Desir
    24. Joseph M. Vinetz

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19

    1. Karin Hardt
    2. An Vandebosch
    3. Jerry Sadoff
    4. Mathieu Le Gars
    5. Carla Truyers
    6. David Lowson
    7. Ilse Van Dromme
    8. Johan Vingerhoets
    9. Tobias Kamphuis
    10. Gert Scheper
    11. Javier Ruiz-Guiñazú
    12. Saul N. Faust
    13. Christoph D. Spinner
    14. Hanneke Schuitemaker
    15. Johan Van Hoof
    16. Macaya Douoguih
    17. Frank Struyf
    18. the ENSEMBLE2 Study Group

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Mutations in SARS-CoV-2 are on the increase against the acquired immunity

    1. Tomokazu Konishi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Neutralizing SARS-CoV-2 Spike Antibodies against Omicron in Paired Samples after Two or Three Doses of mRNA Vaccine

    1. Amanda K. Debes
    2. Shaoming Xiao
    3. Emily R. Egbert
    4. Patrizio Caturegli
    5. Avinash Gadala
    6. Elizabeth Colantuoni
    7. Ioannis Sitaras
    8. Andrew Pekosz
    9. Aaron M. Milstone

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Estimating COVID-19 Vaccination and Booster Effectiveness Using Electronic Health Records From an Academic Medical Center in Michigan

    1. Emily K. Roberts
    2. Tian Gu
    3. Abram L. Wagner
    4. Bhramar Mukherjee
    5. Lars G. Fritsche

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Dynamics of antibody titers and cellular immunity among Japanese healthcare workers during the 6 months after receiving two doses of BNT162b2 mRNA vaccine

    1. Yoshifumi Uwamino
    2. Toshinobu Kurafuji
    3. Kumiko Takato
    4. Akiko Sakai
    5. Akiko Tanabe
    6. Masayo Noguchi
    7. Yoko Yatabe
    8. Tomoko Arai
    9. Akemi Ohno
    10. Yukari Tomita
    11. Ayako Shibata
    12. Hiromitsu Yokota
    13. Wakako Yamasawa
    14. Ho Namkoong
    15. Yasunori Sato
    16. Naoki Hasegawa
    17. Masatoshi Wakui
    18. Mitsuru Murata

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Development and external validation of a mixed-effects deep learning model to diagnose COVID-19 from CT imaging

    1. Joshua Bridge
    2. Yanda Meng
    3. Wenyue Zhu
    4. Thomas Fitzmaurice
    5. Caroline McCann
    6. Cliff Addison
    7. Manhui Wang
    8. Cristin Merritt
    9. Stu Franks
    10. Maria Mackey
    11. Steve Messenger
    12. Renrong Sun
    13. Yitian Zhao
    14. Yalin Zheng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 211 of 716 Next